Skaana Management L.P. Novavax Inc Transaction History
Skaana Management L.P.
- $131 Million
- Q3 2024
A detailed history of Skaana Management L.P. transactions in Novavax Inc stock. As of the latest transaction made, Skaana Management L.P. holds 333,887 shares of NVAX stock, worth $2.93 Million. This represents 3.23% of its overall portfolio holdings.
Number of Shares
333,887
Previous 236,594
41.12%
Holding current value
$2.93 Million
Previous $3 Million
40.77%
% of portfolio
3.23%
Previous 2.65%
Shares
5 transactions
Others Institutions Holding NVAX
# of Institutions
291Shares Held
93.4MCall Options Held
6.95MPut Options Held
9.4M-
Vanguard Group Inc Valley Forge, PA15.4MShares$135 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$104 Million0.0% of portfolio
-
Shah Capital Management9.82MShares$86.1 Million40.63% of portfolio
-
State Street Corp Boston, MA7.69MShares$67.4 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.94MShares$52.1 Million0.07% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $686M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...